OTC Allergy Drugs: Not Just For Sniffles And Headaches, Sanofi Advises
Executive Summary
The US office of Sanofi consumer division says 160 participants wore a wearable device for 30 days to track their sleep and activity. The 80 participants with allergies were less active and slept less.
You may also be interested in...
Xyzal Switch Extends Sanofi Into OTC 24-Hour Children's Antihistamine
FDA approval of Xyzal Allergy 24HR enables Sanofi to compete in the once-daily OTC pediatric antihistamine space in the US.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.